• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫腺癌患者子宫切除术中子宫锥切术结果分析。

Analysis of Conization Results in Patients undergoing Hysterectomy for Uterine Adenocarcinoma.

机构信息

Department of Surgery, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.

出版信息

Rev Bras Ginecol Obstet. 2020 May;42(5):266-271. doi: 10.1055/s-0040-1709191. Epub 2020 May 29.

DOI:10.1055/s-0040-1709191
PMID:32483807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10316853/
Abstract

OBJECTIVE

To observe if the histopathological result of a conization performed after cervical adenocarcinoma in situ diagnosis is compatible with the histopathological analysis of a subsequent hysterectomy.

METHODS

The present descriptive and observational research consisted of the analysis of the medical records of 42 patients who were diagnosed with in situ adenocarcinoma postconization. The analysis consisted of whether there was compatibility between the histopathological reports of conization and hysterectomy and if there was an association between adenocarcinoma in situ and another neoplasia (squamous disease). Interpretation of any immunohistochemistry reports obtained was also performed. In addition, clinical and epidemiological data were also analyzed.

RESULTS

A total of 42 conizations were performed, 33 (79%) were cold knife conizations and 9 (21%) were loop electrosurgical excision procedures (LEEPs). Of the patients analyzed, 5 (10%) chose not to undergo subsequent hysterectomy to preserve fertility or were < 25 years old. Out of the 37 patients with adenocarcinoma in situ who underwent subsequent hysterectomy, 6 (16%) presented with residual disease. This finding proved incompatible with the finding of the conizations, which had ruled out invasive cancer.

CONCLUSION

The prevalence of adenocarcinoma in situ increased in the past years. There is still a large part of the medical literature that advocates the use of conservative treatment for this disease, even though it is common knowledge that it is a multifocal disease. However, the majority of studies advocate that hysterectomy should remain the preferred treatment for women who have already completed their reproductive purpose.

摘要

目的

观察宫颈原位腺癌诊断后行锥切术的组织病理学结果是否与随后行子宫切除术的组织病理学分析一致。

方法

本描述性和观察性研究分析了 42 例经锥切术诊断为原位腺癌后患者的病历。分析内容包括锥切术和子宫切除术的组织病理学报告是否存在一致性,以及原位腺癌与另一种肿瘤(鳞状疾病)是否存在关联。还对获得的任何免疫组织化学报告进行了解读。此外,还分析了临床和流行病学数据。

结果

共进行了 42 例锥切术,其中 33 例(79%)为冷刀锥切术,9 例(21%)为环形电切术(LEEP)。在分析的患者中,有 5 例(10%)因保留生育能力或年龄<25 岁而选择不进行随后的子宫切除术。在 37 例随后行子宫切除术的原位腺癌患者中,有 6 例(16%)有残留疾病。这一发现与锥切术的结果不一致,后者排除了浸润性癌。

结论

近年来,原位腺癌的患病率有所增加。尽管人们普遍认为这是一种多灶性疾病,但仍有很大一部分医学文献主张对这种疾病采用保守治疗。然而,大多数研究主张对于已经完成生育目的的女性,子宫切除术仍然是首选治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c61/10316853/bdb8592739f6/10-1055-s-0040-1709191-i190247-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c61/10316853/bdb8592739f6/10-1055-s-0040-1709191-i190247-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c61/10316853/bdb8592739f6/10-1055-s-0040-1709191-i190247-1.jpg

相似文献

1
Analysis of Conization Results in Patients undergoing Hysterectomy for Uterine Adenocarcinoma.子宫腺癌患者子宫切除术中子宫锥切术结果分析。
Rev Bras Ginecol Obstet. 2020 May;42(5):266-271. doi: 10.1055/s-0040-1709191. Epub 2020 May 29.
2
Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.宫颈原位腺癌治疗后残留疾病和浸润性癌的风险。
Gynecol Oncol. 2013 Jun;129(3):513-6. doi: 10.1016/j.ygyno.2013.03.015. Epub 2013 Mar 28.
3
Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.宫颈原位腺癌锥切:残留疾病的预测模型。
Am J Obstet Gynecol. 2014 Apr;210(4):366.e1-366.e5. doi: 10.1016/j.ajog.2013.12.030. Epub 2013 Dec 24.
4
Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.101例宫颈原位腺癌患者的保留生育功能手术
Gynecol Oncol. 2007 Nov;107(2):316-9. doi: 10.1016/j.ygyno.2007.06.021. Epub 2007 Aug 8.
5
Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.锥切术中进行宫颈管刮除术以预测残留的宫颈原位腺癌。
Gynecol Oncol. 2002 Oct;87(1):129-32. doi: 10.1006/gyno.2002.6791.
6
Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.子宫颈原位腺癌:100例经验
Gynecol Oncol. 2000 Nov;79(2):207-10. doi: 10.1006/gyno.2000.5957.
7
Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.宫颈管搔刮术、宫颈锥切切缘与宫颈原位腺癌残留
Obstet Gynecol. 1997 Jul;90(1):1-6. doi: 10.1016/S0029-7844(97)00122-1.
8
Adenocarcinoma in situ of the uterine cervix: management and outcome.子宫颈原位腺癌:管理与结局
Gynecol Oncol. 1996 Jun;61(3):304-8. doi: 10.1006/gyno.1996.0147.
9
Follow-up of women with cervical adenocarcinoma in situ treated by conization: A single centre clinical experience.宫颈原位腺癌锥切术后的随访:单中心临床经验。
Gynecol Oncol. 2024 Aug;187:74-79. doi: 10.1016/j.ygyno.2024.05.004. Epub 2024 May 10.
10
Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.接受环形电切术/锥切术治疗原位腺癌的女性发生残留原位腺癌或宫颈腺癌的风险。
J Reprod Med. 2011 Sep-Oct;56(9-10):376-80.

本文引用的文献

1
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.《宫颈癌(第 3.2019 版)》,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Jan;17(1):64-84. doi: 10.6004/jnccn.2019.0001.
2
Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis.宫颈腺癌的细胞学模式,重点是与漏诊相关的因素。
Cancer Cytopathol. 2018 Nov;126(11):950-958. doi: 10.1002/cncy.22055. Epub 2018 Oct 23.
3
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
欧洲妇科肿瘤学会/欧洲放射肿瘤学会/欧洲病理学会关于宫颈癌管理患者的指南。
Virchows Arch. 2018 Jun;472(6):919-936. doi: 10.1007/s00428-018-2362-9. Epub 2018 May 4.
4
An overview of cervical cancer epidemiology and prevention in Scandinavia.斯堪的纳维亚地区宫颈癌流行病学和预防概述。
Acta Obstet Gynecol Scand. 2018 Jul;97(7):795-807. doi: 10.1111/aogs.13313. Epub 2018 Feb 23.
5
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.宫颈癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv72-iv83. doi: 10.1093/annonc/mdx220.
6
Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1).子宫颈早期浸润性腺癌(国际妇产科联盟分期IA1期)的外科治疗及结果
Asia Pac J Clin Oncol. 2018 Apr;14(2):e50-e53. doi: 10.1111/ajco.12691. Epub 2017 Apr 21.
7
Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.冷刀锥切术与环形电切术治疗宫颈原位腺癌(ACIS)的比较:一项系统评价和荟萃分析
PLoS One. 2017 Jan 26;12(1):e0170587. doi: 10.1371/journal.pone.0170587. eCollection 2017.
8
Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?子宫颈筛查能预防子宫颈腺癌和腺鳞癌吗?
Int J Cancer. 2016 Sep 1;139(5):1040-5. doi: 10.1002/ijc.30152. Epub 2016 May 6.
9
Detecting uterine glandular lesions: Role of cervical cytology.子宫腺性病变的检测:宫颈细胞学的作用。
Cytojournal. 2016 Feb 22;13:3. doi: 10.4103/1742-6413.177156. eCollection 2016.
10
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.人乳头瘤病毒(HPV)DNA检测在高级别宫颈病变、原位腺癌(AIS)及微浸润癌治疗后随访中的应用
Ecancermedicalscience. 2015 Apr 29;9:528. doi: 10.3332/ecancer.2015.528. eCollection 2015.